THE GENETIC-POLYMORPHISM OF SPARTEINE METABOLISM

被引：88

作者：

EICHELBAUM, M ^{[1
]}

REETZ, KP ^{[1
]}

SCHMIDT, EK ^{[1
]}

ZEKORN, C ^{[1
]}

机构：

[1] UNIV BONN,MED KLIN,D-5300 BONN,FED REP GER

来源：

XENOBIOTICA | 1986年 / 16卷 / 05期

关键词：

D O I：

10.3109/00498258609050252

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：465 / 481

页数：17

共 45 条

[1]

BAUR M, 1984, EUR J CLIN PHARM, V27, P255

[2]

BERNASCONI R, 1965, PHARM ACTA HELV, V40, P275

[3] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE [J].

BERTILSSON, L ;

DENGLER, HJ ;

EICHELBAUM, M ;

SCHULZ, HU .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) :153-155

[4] FURTHER-STUDIES ON CHEMISTRY AND STRUCTURE OF N-OXIDES OF SPARTEINE AND ITS DERIVATIVES .5. SYNTHESIS AND STRUCTURE OF 2-PHENYLSPARTEINE-N16-OXIDE, A NEW CASE OF SPONGE PROTON [J].

BOCZON, W ;

PIECZONKA, G ;

WIEWIOROWSKI, M .

TETRAHEDRON, 1977, 33 (19) :2565-2570

[5]

BOHLMANN F, 1967, ALKALOIDS CHEMISTRY, V9, P175

[6]

BOOBIS AR, 1983, MOL PHARMACOL, V23, P474

[7]

BRAZEAU P, 1965, PHARMACOL BASIS THER, P886

[8] ADVERSE-EFFECTS FROM METOPROLOL ARE NOT GENERALLY ASSOCIATED WITH OXIDATION STATUS [J].

CLARK, DWJ ;

MORGAN, AKW ;

WAALMANNING, H .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (06) :965-967

[9]

Cook A. G., 1969, ENAMINES SYNTHESIS S

[10] THEOPHYLLINE METABOLISM IN RELATION TO ANTIPYRINE, DEBRISOQUINE, AND SPARTEINE METABOLISM [J].

DAHLQVIST, R ;

BERTILSSON, L ;

BIRKETT, DJ ;

EICHELBAUM, M ;

SAWE, J ;

SJOQVIST, F .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (06) :815-821

← 1 2 3 4 5 →